Last updated: Oct 30, 2026, 12:00 AM

Avalo Therapeutics Inc Exchange (NASDAQ, USD)

AVTX

-
+0.32 (+4.49%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-59.52%
3 year return (CAGR)
-33.83%
5 year return (CAGR)
-74.04%
10 year return (CAGR)
-51.24%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
399.01M
Price/Sales
6762.83
Ent value
355.75M
Price/Book
0.89
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-70.18%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Ready to capitalize on Avalo Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
AVTXS&P500
Current price drop from All-time high-99.96%-1.25%
Highest price drop-99.98%-56.47%
Date of highest drop28 May 20259 Mar 2009
Avg drop from high-72.02%-10.65%
Avg time to new high552 days12 days
Max time to new high1930 days1805 days